Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Rineton

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 27 USDMF, 11 CEP/COS, 5 JDMF, 10 EU WC, 21 KDMF, 29 NDC API, 1 VMF, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 232 FDA Orange Book, 83 Europe, 17 Canada, 2 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML, SPRAY;TOPICAL - 0.147MG/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/ML, SPRAY, METERED;NASAL - 0.055MG/SPRAY, FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL, CREAM;TOPICAL - 0.025%, CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.5%, OINTMENT;TOPICAL - 0.025%, OINTMENT;TOPICAL - 0.1%, OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 9 SPI Pharma, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 12 Kirsch Pharma, 5 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 15 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 22 BASF, 3 CD Formulation, 1 Clariant, 2 DFE Pharma, 2 Esteem Industries, 6 Finar, 12 Gangwal Chemicals, 4 Gloria Interchem, 1 Ideal Cures, 1 JJ Chemicals, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 19 Roquette, 12 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

42 Topical, 39 Solubilizers, 37 Parenteral, 36 Thickeners and Stabilizers, 24 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 18 Emulsifying Agents, 16 Surfactant & Foaming Agents, 12 Direct Compression, 12 Coating Systems & Additives, 11 Co-Processed Excipients, 10 Controlled & Modified Release, 9 Taste Masking, 8 API Stability Enhancers, 8 Granulation, 8 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Lubricants & Glidants, 1 Soft Gelatin

DIGITAL CONTENT

111 News #PharmaBuzz

111 News #PharmaBuzz

GLOBAL SALES INFORMATION

53 US Medicaid Prescriptions, 32 Regulatory FDF Prices

MARKET PLACE

30 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/03/2026	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LIMITED New Delhi IN	CEP 2017-167 - Rev 02	Triamcinolone acetonide, Micronised	2024-05-27	Valid	Chemical		533
31/03/2026	Axplora	Germany	FARMABIOS S.p.A Gropello Cairoli IT	R1-CEP 2000-075 - Rev 07	Triamcinolone acetonide, Micronised and non-micronised	2021-02-25	Valid	Chemical		533

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Rineton

Rineton

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers

27 USDMF

11 CEP/COS

5 JDMF

10 EU WC

21 KDMF

29 NDC API

1 VMF

37 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

73 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

232 FDA Orange Book

83 Europe

17 Canada

2 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML

SPRAY;TOPICAL - 0.147MG/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 40MG/ML

INJECTABLE;INJECTION - 80MG/ML

SPRAY, METERED;NASAL - 0.055MG/SPRAY

FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL

CREAM;TOPICAL - 0.025%

CREAM;TOPICAL - 0.1%

CREAM;TOPICAL - 0.5%

OINTMENT;TOPICAL - 0.025%

OINTMENT;TOPICAL - 0.1%

OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

9 SPI Pharma

1 Pharm-RX Chemical

3 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

12 Kirsch Pharma

5 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

15 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

22 BASF

3 CD Formulation

1 Clariant

2 DFE Pharma

2 Esteem Industries

6 Finar

12 Gangwal Chemicals

4 Gloria Interchem

1 Ideal Cures

1 JJ Chemicals

2 Kerry

2 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qualicaps

19 Roquette

12 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

CREAM;TOPICAL - 0.025% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY;TOPICAL - 0.147MG/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons